Evidence map›Paper›PMID 25455978›Full record

ArticleThe Lancet. Infectious diseases2014

Antiretroviral treatment initiation--authors' reply.

Seonaid Nolan, Evan Wood, Julio S G Montaner

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Seonaid NolanBritish Columbia Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Evan WoodBritish Columbia Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Julio S G MontanerBritish Columbia Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, BC, V6Z 1Y6, Canada; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: jmontaner@cfenet.ubc.ca.

Funding

Impacts of universal access to HIV/AIDS care among HIV+ injection drug usersR01DA021525 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MILLOY, M-J · 2007 to 2016
$5.8M
Mentoring the next generation of addiction clinician scientists while responding to the opioid epidemicR25DA037756 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI FAIRBAIRN, NADIA · 2014 to 2023
$3.6M
Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BCR01DA036307 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MONTANER, JULIO SERGIO GONZALEZ · 2013 to 2017
$3.0M
NIDA NIH HHS R01 DA021525NIDA NIH HHS R01 DA036307NIDA NIH HHS R25 DA037756
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV-1Acquired Immunodeficiency SyndromeAIDS-Related Opportunistic InfectionsAnti-Retroviral AgentsFemaleHumansMaleTuberculosis, PulmonaryAnti-Retroviral Agents

Identifiers

PMID25455978
PMCPMC4364602

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.